S Korea: Samsung Biologics begins production of Moderna COVID-19 vaccine

Oct 14, 2021

Seoul [South Korea], October 14 (ANI/Global Economic): Samsung Biologics has begun production of Moderna COVID-19 vaccine and secured supplies before GMP approval.

Samsung Biologics to supply Moderna vaccines in earnest, to become K-bio 'vaccine hub'

Oct 27, 2021

Seoul [South Korea], October 27 (ANI/Global Economic): Moderna's COVID-19 vaccine produced by Samsung Biologics will be supplied domestically and globally, allowing Korea to solidify...

Korean bio 'Big 3' Samsung, Celltrion, SK to expand their businesses in Songdo

Dec 29, 2021

Seoul [South Korea], December 29 (ANI/Global Economic): As SK Bioscience announced its plan to open a new R&PD center in Songdo, Incheon, three Korean...

South Korea: Domestic production of Pfizer vaccine? Samsung Bio and Pfizer's denial still raises expectations

May 13, 2021

Seoul [South Korea], May 13 (ANI/Global Economic): Even though Samsung Biologics denied reports that Pfizer's novel coronavirus infection (COVID-19) vaccine is being produced on...

Moderna's research cooperation with Korea. Will it speed up the development of mRNA vaccines?

May 25, 2021

Seoul [South Korea], May 25 (ANI/Global Economic): During the ROK-US summit, the attention is focused on whether the government will foster the development of...

Biocon Biologics and Voluntis join hands for global collaboration on digital therapeutics for insulins

Jul 21, 2020

Bengaluru (Karnataka) [India], July 21 : Biocon Biologics India Limited, a fully integrated 'pure-play' biosimilars company, a subsidiary of Biocon Ltd. on Tuesday announced...